Thyroxine downregulates Sox9 and promotes chondrocyte hypertrophy

Area of Science:

• Endocrinology
• Skeletal Biology
• Cellular Differentiation

Background:

• Thyroid hormones are crucial for skeletal development, growth, and metabolism.
• Thyroxine (T4) and growth hormone (GH) are key regulators of skeletal homeostasis.
• Chondrocytes in the growth plate are essential for endochondral ossification.

Purpose of the Study:

• To investigate the effects of thyroxine (T4) and growth hormone (GH) on the terminal differentiation of rib growth plate chondrocytes.
• To elucidate the molecular mechanisms by which T4 influences chondrocyte maturation.
• To determine if GH modulates the action of T4 on chondrocytes.

Main Methods:

• Three-dimensional pellet culture of rib growth plate chondrocytes.
• Treatment with thyroxine (T4) and/or growth hormone (GH).
• Analysis of gene expression (collagens, Sox9), alkaline phosphatase (ALP) activity, and cellular hypertrophy.

Main Results:

• T4 (30ng/ml) significantly stimulated the expression of type II and X collagens and alkaline phosphatase (ALP) activity.
• T4 treatment led to a significant decrease in the expression of the chondrogenic transcription factor Sox9.
• T4 markedly increased type X collagen mRNA synthesis, ALP activity, and cellular hypertrophy by day 7.
• Growth hormone (GH) did not alter the effects of T4 on chondrocytes.

Conclusions:

• Thyroxine (T4) directly acts on chondrocytes to promote terminal differentiation and hypertrophy.
• T4 downregulates Sox9 expression, a key event in the transition from proliferation to hypertrophy.
• T4 enhances the cellular and molecular processes involved in chondrocyte maturation and skeletal development.